Severe headaches following smallpox vaccination

Headache

Volumn 45, Issue 1, 2005, Pages 87-88

  Sejvar, James ^a   Boneva, Roumiana ^b   Lane, J Michael ^c   Iskander, John ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Adverse events; Headache; Smallpox vaccination

Indexed keywords

SMALLPOX VACCINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; HEADACHE; HOSPITALIZATION; HUMAN; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SMALLPOX; UNITED STATES;

ADULT; FEMALE; HEADACHE; HUMANS; MALE; MIDDLE AGED; SMALLPOX VACCINE;

EID: 11844253920     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2005.t01-5-05013.x     Document Type: Article

References (3)

1. Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med. 2002;346:1265-1274.
2. Singleton JA, Lloyd JL, Mootrey GL, Salive ME, Chen RT: An overview of the Vaccine Adverse Event Reporting System (VAERS) as a surveillance system. Vaccine. 1999;17:2908-2917.
3. Zhou W, Pool V, Iskander J, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2000. In: CDC Surveillance Summaries (Jan 24). Morb Mortal Wkly Rep. 2003;52(No. SS-1):18-19.